Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation
C Fernández de Larrea, C Martínez, A Gaya, et al.
British Journal of Haematology
|
November 25, 1998
Molecular characterization of the PK-LR gene in pyruvate kinase deficient Spanish patients. Red Cell Pathology Group of the Spanish Society of Haematology (AEHH)
R Zarza, R Alvarez, A Pujades, et al.
Medicina Clinica
|
June 22, 1999
[Molecular study of red cell pyruvate kinase deficiency in 15 patients with chronic hemolytic anemia. Group of Erythropathology of Hematology and hemotherapy Association of Spain (HHAS)]
R Zarza, A Pujades, J García, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
S Montoto, A López-Guillermo, A Altés, et al.
Blood
|
September 6, 2001
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
C E Dearden, E Matutes, B Cazin, et al.
Leukemia
|
May 7, 2015
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T Bernal, P Martínez-Camblor, J Sánchez-García, et al.
Leukemia Research
|
December 3, 2011
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome
I Cordoba, J R Gonzalez-Porras, E Such, et al.
Medicina Clinica
|
May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]
C Rozman, E Carreras, J Sierra, et al.
Leukemia
|
June 30, 2020
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS
A Kuendgen, M Nomdedeu, H Tuechler, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation
C Fernández de Larrea, C Martínez, A Gaya, et al.
British Journal of Haematology
|
November 25, 1998
Molecular characterization of the PK-LR gene in pyruvate kinase deficient Spanish patients. Red Cell Pathology Group of the Spanish Society of Haematology (AEHH)
R Zarza, R Alvarez, A Pujades, et al.
Medicina Clinica
|
June 22, 1999
[Molecular study of red cell pyruvate kinase deficiency in 15 patients with chronic hemolytic anemia. Group of Erythropathology of Hematology and hemotherapy Association of Spain (HHAS)]
R Zarza, A Pujades, J García, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
S Montoto, A López-Guillermo, A Altés, et al.
Blood
|
September 6, 2001
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
C E Dearden, E Matutes, B Cazin, et al.
Leukemia
|
May 7, 2015
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T Bernal, P Martínez-Camblor, J Sánchez-García, et al.
Leukemia Research
|
December 3, 2011
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome
I Cordoba, J R Gonzalez-Porras, E Such, et al.
Medicina Clinica
|
May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]
C Rozman, E Carreras, J Sierra, et al.
Leukemia
|
June 30, 2020
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS
A Kuendgen, M Nomdedeu, H Tuechler, et al.
Page
of 4